Rescinnamine
Clinical data | |
---|---|
Trade names | Moderil, Cinnasil, Anaprel |
Routes of administration | oral |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
Synonyms | methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-{[(2E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}-3,13-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-2(10),4(9),5,7-tetraene-19-carboxylate |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
ECHA InfoCard | 100.042.232 |
Chemical and physical data | |
Formula | C35H42N2O9 |
Molar mass | 634.716 g/mol |
3D model (JSmol) | |
| |
| |
(verify) |
Rescinnamine is an angiotensin-converting enzyme inhibitor used as an antihypertensive drug.
It is an vinca alkaloid obtained from Rauwolfia serpentina[1] and other species of Rauwolfia.[2]
Brand names
Moderil, Cinnasil, Anaprel
References
- ↑ FIFE R, MACLAURIN JC, WRIGHT JH (December 1960). "Rescinnamine in treatment of hypertension in hospital clinic and in general practice". British Medical Journal. 2 (5216): 1848–50. PMC 2098607 . PMID 13699407. doi:10.1136/bmj.2.5216.1848.
- ↑ Balsevich J, Constabel F, Kurz WG (1982). "Alkaloids of Vinca major cv. Variegata.". Planta Med. 44 (2): 91–3. PMID 17402086. doi:10.1055/s-2007-971409.
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.